Safety and Efficacy of Concurrent or Sequential Radiotherapy Plus (PD-1) Inhibitors in Oligometastatic Esophageal Cancer

PURPOSE: We assess real-world outcomes, including safety and efficacy, of concurrent or sequential treatment with radiotherapy plus programmed cell death protein 1 (PD-1) inhibitors in patients with oligometastatic esophageal cancer (OMEC). METHODS: This cohort study retrospectively collected clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Yanan, Qin, Wenru, Yang, Linlin, Zou, Bing, Qie, Wenting, Song, Ruiting, Xue, Lu, Wang, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849787/
https://www.ncbi.nlm.nih.gov/pubmed/36685716
http://dx.doi.org/10.2147/CMAR.S391529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849787/
https://www.ncbi.nlm.nih.gov/pubmed/36685716
http://dx.doi.org/10.2147/CMAR.S391529

Ejemplares similares